Clofazimine pharmacokinetics in patients with TB: dosing implications

BACKGROUND: Clofazimine is in widespread use as a key component of drug-resistant TB regimens, but the recommended dose is not evidence based. Pharmacokinetic data from relevant patient populations are needed to inform dose optimization. OBJECTIVES: To determine clofazimine exposure, evaluate covari...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Antimicrob Chemother
Hlavní autoři: Abdelwahab, Mahmoud Tareq, Wasserman, Sean, Brust, James C M, Gandhi, Neel R, Meintjes, Graeme, Everitt, Daniel, Diacon, Andreas, Dawson, Rodney, Wiesner, Lubbe, Svensson, Elin M, Maartens, Gary, Denti, Paolo
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566350/
https://ncbi.nlm.nih.gov/pubmed/32747933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa310
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky